The Joint Commission revises anticoagulant therapy national patient safety goal: 3 details

The Joint Commission revised its national patient safety goal for anticoagulant therapy in ambulatory care settings.

Advertisement

The key details to know:

1. The revisions address patient and family education, patient monitoring, approved protocols and new practices for Heparin and Warfarin use.

2. The guidelines take effect July 1. and the goal doesn’t apply to episodic and occupational health providers.

3. The new goal aims to help prevent adverse drug events.

Read more here.

More articles on accreditation:
Crater Lake Surgery Center earns AAAHC accreditation — 3 highlights
How HFAP’s change of ownership affects accredited ASCs — 4 insights
The Joint Commission debuts infection prevention initiative

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Accreditation, Licensure & Medicare Certification

Advertisement

Comments are closed.